ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 18 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $639 | -90.0% | 868 | -82.8% | 0.00% | – |
| Q2 2023 | $6,372 | +75.0% | 5,057 | +0.7% | 0.00% | – |
| Q1 2023 | $3,642 | +749.0% | 5,023 | +519.4% | 0.00% | – |
| Q4 2022 | $429 | -57.1% | 811 | +2.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 790 | -6.7% | 0.00% | – |
| Q2 2022 | $1,000 | -96.9% | 847 | -96.6% | 0.00% | – |
| Q1 2022 | $32,000 | -69.5% | 24,938 | -62.0% | 0.00% | – |
| Q4 2021 | $105,000 | +1400.0% | 65,652 | +5540.2% | 0.00% | – |
| Q2 2021 | $7,000 | +250.0% | 1,164 | +20.7% | 0.00% | – |
| Q1 2021 | $2,000 | – | 964 | +1317.6% | 0.00% | – |
| Q4 2020 | $0 | – | 68 | +6.2% | 0.00% | – |
| Q3 2020 | $0 | – | 64 | +4.9% | 0.00% | – |
| Q2 2020 | $0 | – | 61 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 61 | -26.5% | 0.00% | – |
| Q3 2018 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |